New weekly diabetes drug shows promise in major trial
Disease control
Completed
This study tested whether a new weekly injection called XW003 could help control blood sugar in adults with type 2 diabetes when diet and exercise alone weren't enough. For 24 weeks, participants received either XW003 or a placebo injection, followed by 28 weeks where everyone re…
Phase: PHASE3 • Sponsor: Hangzhou Sciwind Biosciences Co., Ltd. • Aim: Disease control
Last updated Mar 11, 2026 14:54 UTC